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ABSTRACT
Neuroinflammation is a hallmark of Alzheimer’s disease and TNFα as the main 
inducer of neuroinflammation has neurodegenerative but also pro-regenerative 
properties, however, the dose-dependent molecular changes on signaling pathway 
level are not fully understood. We performed quantitative proteomics and phospho-
proteomics to target this point. 
In HT22 cells, we found that TNFα reduced mitochondrial signaling and inhibited 
mTOR protein translation signaling but also led to induction of neuroprotective MAPK-
CREB signaling. Stimulation of human neurons with TNFα revealed similar cellular 
mechanisms. Moreover, a number of synaptic plasticity-associated genes were altered 
in their expression profile including CREB. 
SiRNA-mediated knockdown of CREB in human neurons prior to TNFα stimulation 
led to a reduced number of protein/phospho-protein hits compared to siRNA-mediated 
knockdown of CREB or TNFα stimulation alone and countermeasured the reduced 
CREB signaling. In vivo data of TNFα knockout mice showed that learning ability did 
not depend on TNFα per se but that TNFα was essential for preserving the learning 
ability after episodes of lipopolysaccharide-induced neuroinflammation. This may be 
based on modulation of CREB/CREB signaling as revealed by the in vitro / in vivo data.
Our data show that several molecular targets and signaling pathways induced 
by TNFα in neurons resemble those seen in Alzheimer´s disease pathology.
INTRODUCTION
Elevated levels of the cytokine tumor necrosis factor-α 
(TNFα) have been associated with neurodegenerative 
diseases such as Alzheimer´s disease (AD) where increased 
levels of TNFα has been found in brains and cerebrospinal 
fluid of AD patients [1]. Systemic inflammation leading 
to increased TNFα is associated with disease progression/
cognitive decline in AD patients [2], and systemic 
challenge, such as administration of lipopolysaccharide 
(LPS), can provoke waves of TNFα expression in the 
rodent brain [3]. The signaling events triggered by TNFα 
that culminate into neurodegeneration are still unclear 
but may include an imbalance in molecular pathways 
where TNFα contributes to neuronal injury but also exerts 
protective effects [4]. Accumulating knowledge from trials 
investigating anti-inflammatory drugs as candidates to 
prevent or slow progression of neurodegenerative diseases 
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have also revealed controversial results [5]. Similarly, 
TNFα inhibitors have been used to eliminate TNFα in order 
to prohibit cell death in an AD phase 2 trial [6] but only 
with marginal effects. These observations may rely on the 
reductions of the neuroprotective properties of cytokines 
and suggests that a better understanding of the pathway 
dynamics is mandatory. 
TNFα acts on the two receptors, TNFR1 and 
TNFR2, which are generally hold to have opposing 
effects e.g. on cell survival [7]. TNFR1, which contains 
a death domain, mainly shows neurodegeneration 
signaling although it also reveals neuroprotection 
in vivo [8] while TNFR2, which is without a death domain, 
is neuroprotective [9]. Importantly, it has been shown 
that local increase of TNFα in the hippocampal dentate 
gyrus activates astrocytic TNFR1, which in turn triggers 
an astrocyte-neuron signaling cascade that results in the 
persistent functional decline of hippocampal excitatory 
synapses [10]. In this context, TNFα exerts additional 
control of hippocampal synapses via α-amino-3-hydroxy-
5-methyl-4-isoxazolepropionic acid (AMPA) [11] 
and gamma-aminobutyric acid (GABA) [12] receptor 
trafficking emerging as a key physiological regulator 
of hippocampal synaptic plasticity and modulator of 
neural injury [13]. Notably, it has been shown that 
TNFR1-triggered signaling might mediate mitochondrial 
function and induces apoptosis in neurons in vitro [13]. 
Neuroprotection via TNFR2 signaling may involve 
upregulation of BDNF protein, decrease in glutaminase 
levels and modulation of N-methyl-D-aspartate (NMDA) 
receptors [14]. Despite the fact that each receptor type 
mediates distinct cellular responses, there are also 
evidences of considerable overlap of their signaling 
capabilities in mediating biological outcomes [15–17]. 
Noteworthy, TNFR1-mediated apoptosis occurs during 
high TNFα levels whereas small amounts of TNFα in the 
low ng/ml range activate the TNFR2-mediated signaling 
cascade [7, 18].
We believe that the underlying molecular 
mechanisms and cellular responses of TNFα need to 
be investigated in a dose-dependent and global manner 
in order to better understand AD etiology and other 
neurological diseases where TNFα plays a pivotal role 
in triggering neuroinflammation and affecting synaptic 
plasticity. 
RESULTS
Dose-dependent inhibition of cell proliferation 
and induction of apoptosis by TNFα in HT22 
cells
To investigate dose-dependency of TNFα on 
HT22 neuronal cells, we incubated 2500 cells/well and 
5000 cells/well with increasing TNFα concentrations 
from 0.1 ng/ml to 100.0 ng/ml for 24 hours. We observed 
a dose-dependent inhibition of cell proliferation starting at 
1.0 ng/ml whereas cell death was induced already at 
0.1 ng/ml TNFα (Figure 1A and 1B). Based on these 
observations, we performed further experiments with a 
maximal dose of 10.0 ng/ml and excluded 100.0 ng/ml as 
it may over-induce apoptosis signaling (Figure 1B). 
Global mass spectrometry-based protein and 
phospho-protein quantification reveals dose-
dependent impairment in energy metabolism 
and synaptic plasticity in HT22 cells
To elucidate the molecular mechanism behind 
low dose (0.1 and 1.0 ng/ml) and moderate TNFα 
concentrations (10.0 ng/ml), we performed a global 
quantitative proteome and phospho-proteome analysis 
after 30 minutes and 24 hours of TNFα stimulation in 
HT22 cells. We noted that the number of significantly 
changed proteins (0.1 ng/ml/1 ng/ml: 0/1 (30 minutes) 
and 0/4 (24 hours)) and phospho-proteins (0.1 ng/ml/ 
1 ng/ml: 0/0 (30 minutes) and 1/0 (24 hours)) induced by 
the two lower TNFα concentrations are scarce compared 
with the high numbers of alterations seen at 10.0 ng/ml 
dose (proteins: 106 (30 minutes) and 778 (24 hours); 
phospho-proteins: 1 (30 minutes) and 287 (24 hours)) 
(Figure 2A, Supplementary Table 5). Supplementary 
Tables 1–4 show the identifiable and quantifiable protein 
and phospho-protein hits.
Bioinformatics analysis of signaling pathways using 
IPA software showed that energy production (Glycolysis, 
Gluconeogenesis, Oxidative Phosphorylation and 
Mitochondrial Dysfunction) and cell proliferative / protein-
translational signaling pathways (Eif2 Signaling, mTOR 
Signaling, Regulation of eiF4 and p70S6K Signaling) as 
well as synaptic plasticity-associated signaling (Signaling 
by Rho Family GTPases and Remodeling of Adherens 
Junctions) were not changed at the 30 minutes time point 
either at protein or phospho-protein level (Figure 2A). 
However, we noted that the affected signaling pathways 
were all significantly modulated by a TNFα dose of 10 ng/
ml after 24 hours of incubation on the protein level whereas 
only EIF2 Signaling, mTOR Signaling and Regulation 
of eif4 and p70S6K Signaling correlated in addition on 
phospho-level to the pathways changes seen on protein 
level (Figure 2A). Notably, we observed a significant 
inhibition of mTOR at 10.0 ng/ml TNFα stimulation for 
24 hours (Figure 2A and 2B) based on our deregulated 
proteins (Supplementary Table 5) 
TNFα-stimulation of HT22 cells leads to 
reduction in mitochondrial protein expression 
and activation of synaptic plasticity-associated 
CREB signaling
To validate the TNFα-induced changes in signaling 
pathways, we performed immunoblotting of key 
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proteins associated within these signaling pathways. 
The mitochondrial proteins Atp5a (Complex V) and 
Uqcrc2 (Complex III) but not Sdhb (Complex II) or 
Ndufb8 (Complex I) were significantly reduced in their 
expression levels after 24 hours of TNFα incubation 
only at a dose of 1.0 and 10.0 ng/ml (Figure 3A and 3B) 
correlating well with the bioinformatics-based deregulated 
signaling pathways of Oxidative Phosphorylation and 
Mitochondrial Dysfunction at these doses (Figure 2A). 
Proteomics revealed an increased protein expression 
of Mtco2 and Cox3 (Complex IV) at 1.0 ng/ml as well 
as increased protein expression of Atp5l (Complex V) 
and a number of abundance alterations of Complex I 
proteins (decrease in Ndufs7, Ndufs8, Ndufc2; increase 
in Ndufs2) at 10.0 ng/ml 24 hours TNFα stimulation for 
24 hours (Supplementary Table 5). Sdhb (Complex II) 
was significantly increased in the proteomics data set 
(Supplementary Table 5) whereas immunoblotting showed 
no change (Figure 3A and 3B).
Next, we quantified CREB and p-CREB levels as 
they are essential synaptic plasticity regulators within 
neurons and modulate Rho signaling [19] which we noted 
Figure 1: TNFα dose-dependent evaluation of cell proliferation and apoptosis in HT22 cells. Cell proliferation (A) and 
apoptosis (B) was quantified by CellTiter-Glo® Cell viability assay and Caspase-Glo® 3/7 assay, respectively. Cells were cultured with a 
density of 2500 or 5000 per well in 96-well plates. The cells were stimulated with 0.1, 1, 10 or 100 ng/ml TNFα for 24 hours and untreated 
cells served as control. The figures show the fold-change and the standard error of the mean of five biological replicates per group. 
Statistical analysis was performed with unpaired Student´s test; *p < 0.05; **p < 0.01; ***p < 0.001.
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to be affected in HT22 neurons by TNFα (Figure 2A). 
We observed that p-CREB but not CREB levels were 
significantly increased at a dose of 10.0 ng/ml TNFα 
whereas their pattern was not changed at lower doses 
(Figure 3C and 3D). 
To validate our observations in cell proliferative / 
protein translational signaling pathways, we quantified 
MAPK (Erk1/2), p-MAPK (p-Erk1/2) as well as total 
phospho-proteins with PKA and PKC phosphorylation 
consensus motif as surrogates for these pathways as 
mTOR and MAPK pathways converge on eIF4 signaling 
[20]. We only noted an increase in MAPK but not 
p-MAPK levels at a dose of 10.0 ng/ml TNFα (Figure 
3C and 3D) that was accompanied by a decrease in total 
PKA upstream of MAPK signaling but not PKC activity 
as revealed by phospho-PKA/-PKC Substrate Antibody 
immunoblotting (Figure 3E and 3F). 
Increased cell proliferation potential by low-dose 
TNFα stimulation in human neurons
Next, we changed our in vitro model to human 
embryonic stem cell-derived neurons to elucidate the 
molecular neuronal mechanism of TNFα closer to human 
neuronal physiology. By using immunofluorescence, we 
show that the differentiation process resulted in a neuronal 
population (β-tub III staining) with very few Ki67-
positive proliferating NSCs and a substantial number of 
GABAergic neurons (Supplementary Figure 1). Moreover, 
very few GFAP-positive astrocytes were observed in the 
cultures (not shown).
We also investigated the dose-dependency of TNFα 
and its influence on cell death and cell proliferation. We 
noted that apoptosis is significantly induced by 100.0 
ng/ml TNFα stimulation over 24 hours but not at lower 
doses (Figure 4B) whereas cell proliferation was increased 
at 0.1 ng/ml, 1.0 ng/ml and 10.0 ng/ml dose but not at 
100.0 ng/ml dose (Figure 4A) in human neurons. 
TNFα influences signaling pathways of mTOR, 
protein synthesis and mitochondrial function in 
human neurons
Global mass spectrometry-based proteomics and 
phospho-proteomics of 1.0 ng/ml TNFα stimulation of 
human neurons over 24 hours showed a deregulation 
of 20 proteins and 23 phospho-proteins (Figure 5A, 
Supplementary Table 10). Supplementary Tables 6–9 
show the identifiable and quantifiable proteins and 
phospho-proteins. Bioinformatics analysis of signaling 
Figure 2: Analysis of signaling pathways from proteomics and phospho-proteomics experiments in HT22 cells. Altered 
TNFα dose-dependent signaling pathways in HT22 cells on the proteome and phospho-proteome using Ingenuity Pathway Analysis 
software are shown in panel (A) High colour intensity represents high significance (p value) of the pathway. All coloured boxes have a p 
value ≤ 0.05; white boxes have a p value ≥ 0.05 and are not significantly changed; n = 3 in each group. Panel (A and B) show the upstream 
regulator analysis from IPA software (z-score > 2.0: predicted significant activation of node; z-score < 2.0: predicted significant inhibition 
of node) were grouped and visualized from proteins (unmodified) of 10 ng/ml TNFα stimulation over 24 hours. There was no significant 
change in the other groups. 
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pathways using IPA software showed changes in 
mitochondrial function (Oxidative Phosphorylation, 
Mitochondrial Dysfunction) and cell proliferative/protein-
translational signaling pathways (Eif2 Signaling, mTOR 
Signaling, Regulation of eiF4 and p70S6K Signaling) 
(Figure 5A). 
Altered mitochondrial function was validated by a 
MitoMP assay but did not show any dose-dependent TNFα 
differences (Figure 5B) although proteomics data indicate 
an increase in protein subunits of CIV (COX5A) and CV 
(ATP5O) (Supplementary Table 10). Moreover, ROS levels 
were also unchanged by dose-dependent TNFα incubation 
in human neurons over 24 hours (Figure 5C). Thus, 
alterations in ROS signaling seems to be not attributable for 
apoptosis induction (Figure 4B), cell proliferation elevation 
(Figure 4A) and -signaling (Figure 5A).
SiRNA-mediated knockdown of CREB prior to 
TNFα stimulation leads to less changed proteins 
and phospho-proteins compared to knockdown 
or TNFα treatment alone in human neurons 
CREB is a transcription factor connecting a 
multitude of pathways related to neuronal metabolism/
proliferation, synaptic plasticity and mitochondrial 
function [21], that were affected targets in our HT22 cell 
study (Figures 1–3) accompanied by elevated levels of 
p-CREB (Figure 3C and 3D). Therefore, we performed 
a siRNA-mediated knockdown of CREB protein in 
human neurons prior to TNFα treatment to investigate 
the CREB/CREB signaling contribution toward the 
molecular mechanism of TNFα. The siRNA treatment 
resulted in an average CREB knockdown efficiency of 
50% (siRNA5: 48% and siRNA7: 53% compared to all-
star negative controls; n = 2) as shown by immunoblotting 
(Supplementary Figure  2). 
Controls (negative – Allstar transfection; positive 
– H
2
O
2
 stimulation) revealed no changes in signaling 
pathways both at protein (Allstar and H
2
O
2
) and phospho-
protein level (Allstar) (Figure 5A) whereas 20/185 proteins 
(Allstar/H
2
O
2
) and 19/80 phospho-proteins (Allstar/H
2
O
2
) 
were altered in their expression profile (Supplementary 
Table 10). Supplementary Tables 6–9 show the identifiable 
and quantifiable proteins and phospho-proteins. Only 
mTOR Signaling, Regulation of eIF4 and p70S6K 
Signaling, EIF2 Signaling and Signaling by Rho Family 
GTPases were deregulated on the phosphorylation status 
by H
2
O
2
 stimulation (Figure 5A). 
SiRNA-mediated knockdown of CREB using two 
independent siRNAs approaches (siRNA5 and siRNA7) 
Figure 3: Immunoblotting of targets involved in mitochondrial function, synaptic plasticity and mTOR signaling in 
HT22 cells. Data from immunoblots of mitochondrial protein subunit expression (A), CREB, p-CREB, MAPK and p-MAPK (C) as well 
as PKA and PKC motif immunoblotting (E) are depicted from 0 ng/ml, 0.1 ng/ml, 1.0 ng/ml and 10.0 ng/ml TNFα stimulation over 24 hours 
in HT22 cells. The columns represent the fold-changes with standard errors of the mean [67]; n = 3; *p < 0.05; **p < 0.01; ***p < 0.001 
(unpaired Student s t-test). Normalization was performed against endogenous GAPDH for mitochondrial proteins as well as PKA and 
PKC motif immunoblotting; CREB, p-CREB, MAPK and p-MAPK were normalized against total lane intensity via Ponceau S staining. 
Representative visualisation of the immunoblotting data is shown in Panel B, D and F.
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affected CREB Signaling in Neurons and Signaling by Rho 
Family GTPases on the proteome and phospho-proteome 
level (siRNA5/siRNA7: proteome 4/2; phospho-proteome 
29/43) (Figure 5A). Rho GTPases such as Rac1 and Cdc42 
playing a fundamental role of CREB activity regulation 
[22–24]. CREB protein expression was significantly 
down-regulated as observed by immunoblotting 
(Supplementary Figure 2) whereas proteomics showed a 
tendency of downregulation (Supplementary Table 11). 
Further signaling pathways on the phospho-proteome 
level were affected by siRNAs but not by both 
simultaneously (Figure 5A) indicating only random 
hits. Most proteins and phospho-proteins overlap within 
the two siRNA knockdown approaches (Supplementary 
Table 10 – highlighted in green). Importantly, siRNA-
mediated CREB knockdown prior to 1.0 ng/ml TNFα 
stimulation does neither alter CREB signaling nor Rho 
Family GTPase signaling with 0/1 altered proteins 
and 9/14 phospho-proteins for siRNA5+TNFα and 
siRNA7+TNFα, respectively (Figure 5A, Supplementary 
Figure 4: TNFα dose-dependent evaluation of cell proliferation and apoptosis in human neurons. Cell proliferation 
(A) and apoptosis (B) was quantified by CellTiter-Glo® Cell viability assay and Caspase-Glo® 3/7 assay, respectively. Cells were cultured 
with a density of 7000 cells per well (96-well plates). The cells were stimulated with 0.1, 1, 10 or 100 ng/ml TNFα over 24 hours and 
untreated cells served as control. The figures show the fold-change and the standard error of the mean of 7-8 biological replicates per group. 
Statistical analysis was performed with unpaired Student´s test; *p < 0.05; **p < 0.01; ***p < 0.001.
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Table 10). Immunoblotting of CREB demonstrated that 
the CREB protein levels were not changed by 1.0 ng/ml 
TNFα whereas siRNAs and H
2
O
2
 stimulation significantly 
reduces expression levels (Supplementary Figure 2). 
Importantly, Allstar and siRNAs+TNFα did not affect 
CREB expression (Supplementary Figure  2) correlating 
with our pathway analysis results (Figure 5A). 
Gene expression analysis reveals impairment 
in synaptic plasticity by TNFα stimulation in 
human neurons
Next, we quantified 84 mRNAs related to synaptic 
plasticity to investigate the molecular mechanism of 
TNFα in more detail. Thirteen gene transcripts were 
significantly down-regulated in their expression profile 
in human neurons treated with 1.0 ng/ml TNFα for 24 
hours (Figure 6, Supplementary Table 12) including 
neuronal receptors (GABRA5, GRIA3, GRIN2A, 
GRM3), neurotrophic factors (BDNF, NTF4), cell-matrix 
modulators (ADAM10, MMP9, PCDH8), cellular stress 
responder (NFKB1) and neurotransmission regulators 
(CAMK2G, CREB1, GNAI1).
TNF knockout mice have learning- and 
memory-related cognitive deficits after 
lipopolysaccharide-induced inflammation 
Our in vitro data indicated that TNFα may be 
important in the memory-related CREB signaling 
regulation in neurons. Thus, we questioned if knockout 
of TNFα in mice affects hippocampal-dependent 
learning and memory-related behaviour, which we did 
by exposing TNFα knockout and age-matched C57BL/6 
mice to the Barnes maze. Both groups of mice quickly 
learned to locate the goal box and the latency times of 
Figure 5: Analysis of signaling pathways from proteomics and phospho-proteomics experiments and quantification 
of mitochondrial membrane potential as well as reactive oxygen species levels in human neurons treated with TNFα. 
Altered signaling pathways in human neurons on the proteome and phospho-proteome using Ingenuity Pathway Analysis software are 
shown in panel (A) with the following treatment groups over 24 hours: TNFα-dose of 1 ng/ml alone, Allstar as transfection control, siRNA5 
and siRNA7 against CREB expression, siRNA5 and siRNA7 knockdown prior to 24 hours TNFα (1 ng/ml) incubation and H
2
O
2
 incubation 
serving as positive control. High colour intensity represents high significance (p value) of the pathway. All coloured boxes have a p value 
≤ 0.05; white boxes have a p value ≥ 0.05 and are not significantly changed; n = 2 in each group. Panel (B and C) show mitochondrial 
membrane potential (MitoMP) and reactive oxygen species (ROS) quantification from 7000 cells per well showing the fold-change and the 
standard error of the mean of 7–8 biological replicates per group. Statistical analysis was performed with unpaired Student´s test; *p < 0.05; 
**p < 0.01; ***p < 0.001.
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Figure 6: Quantification of the expression of genes involved in synaptic plasticity after 1.0 ng/ml TNFα stimulation 
over 24 hours in human neurons. Genes significantly changed in expression after 1.0 ng/ml TNFα stimulation for 24 hours compared 
to untreated human neurons using RT2 Profiler PCR Arrays (Qiagen) are shown. The table shows the genes which are significantly up-
regulated or down-regulated compared to controls in a heat-map presentation; *p < 0.05; **p < 0.01; ***p < 0.001 (unpaired Student’s 
t-test, n = 3).
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both groups were significantly decreased from day 2 
of the 6 days the mice were tested, with no difference 
between the groups (Figure 7A), indicating that TNFα is 
not required for learning under normal conditions. Next, 
the TNFα knockout and C57BL/6 mice were challenged 
by inducing an inflammatory reaction by intraperitoneal 
LPS injection on days 7 and 4 prior to learning. The time 
of the injections was guided by observations obtained 
in the Morris water maze, showing that water maze-
induced learning promotes the survival of the granule 
cell precursors born a few days prior to induction of the 
learning experience [25]. As expected, LPS-injected mice 
displayed sickness behaviour that ceased 2–3 days after 
the last LPS-injection, which was 1–2 days prior to the 
time point where the mice were exposed to the Barnes 
maze protocol (taking place 4 days after the last LPS-
injection). Interestingly, the LPS-injected TNFα knockout 
mice were extremely slow learners compared to the LPS-
injected C57/BL6 mice (Figure 7B). Comparative analysis 
of toluidine blue stained coronal brain sections revealed 
no histoarchitectonic abnormalities in LPS-injected TNFα 
knockout compared to LPS-injected C57/BL6 mice. In 
particular, the hippocampus, which is involved in spatial 
learning and memory, had completely normal appearing 
granule and pyramidal cell layers and normal appearing 
neuropil layers along the entire rostrocaudal axis (data 
not shown). No changes in weight of the LPS-injected 
TNFα knockout or C57BL/6 mice were observed over the 
experiment (data not shown). 
To explore the connection between TNFα and 
CREB signaling under physiological and LPS-induced 
inflammatory conditions, corresponding to those induced 
at 7 or 4 days prior to the Barnes maze-induced learning 
experience, we next challenged three-month-old C57BL/6 
and TNFα knockout mice to a single intraperitoneal 
injection with either LPS (0.5 mg/kg) or vehicle PBS and 
sacrificed them 4 hours after the injections corresponding 
to the time when inflammation peaks in the brain after 
LPS-injection [26]. Subsequently, the hippocampus 
was isolated and CREB, p-CREB immunoblotting was 
performed. Figure 7C–7E show a significant reduction of 
p-CREB levels in LPS-treated versus PBS-treated TNF-
KO mice in the hippocampus whereas CREB/p-CREB 
ratios were unchanged between C57BL/6 and TNF-KO 
regardless of PBS and LPS-stimulation.
These data demonstrate that acute LPS-induced 
inflammation prior to learning affects hippocampus-
dependent learning ability in TNFα  knockout mice 
whereas modulation of CREB signaling seems to be an 
important molecular target in the LPS response.
DISCUSSION
To characterise neurodegenerative and pro-
neurogenic properties of TNFα, we used quantitative 
proteomics and phospho-proteomics in HT22 neuronal 
cells and human embryonic stem cell-derived neurons 
to elucidate the differences in signaling pathway profiles 
that are associated with the distinct molecular properties 
of TNFα. Furthermore, we performed experiments with 
siRNA-mediated CREB knockdown and behavioral 
learning analysis of TNFα knockout mice compared to 
wild type mice performance challenged with LPS.
HT22 cells are suitable as neuronal model to study 
TNFα signaling since they express both receptor subtypes 
for TNFα (TNFR1 and TNFR2) under normal culture 
conditions [13]. It has previously been shown that HT22 
cells treated with TNFα at concentrations of 1.0 and 
10.0 ng/ml for 4 hours lead to up-regulation of Homer1a 
and Egr2 [27], whereas both molecules are important 
in synaptic plasticity and memory formation. These 
data correlate well with our noted activation of CREB-
mediated signaling at a dose of 10.0 ng/ml over 24 hours 
as Homer1a [28] and Egr2 [29] are CREB-dependent 
genes. As MAPK signaling is an upstream regulator 
of CREB signaling, the increase in MAPK at a dose of 
10.0 ng/ml TNFα correlates with potential higher CREB 
activity. Scientific data indicate that an elevated MAPK 
signaling is involved in early stages of AD [30–32]. 
Importantly, the increased MAPK signaling in AD occurs 
via cellular stress arising from different factors such as 
TNFα [33].
It has been reported that pretreatment (24 hours) 
of murine hippocampal slice cultures with 10.0 ng/
mL TNFα potentiated AMPA-induced neuronal death 
[18]. Moreover, Doll et al. noted that TNFα stimulation 
of HT22 cells decreased the cell viability. They also 
demonstrated that TNFα exerts its neurotoxic effects 
through TNFR1 but not TNFR2 accompanied with 
apoptosis induction and decreased mitochondrial 
membrane potential [13]. We also observed a dose-
dependent alleviation in cell proliferation and induction 
of apoptosis by TNFα in HT22 cells. Importantly, only a 
dose of 10.0 ng/ml TNFα led to significant alterations of 
signaling pathways associated to cell metabolism, protein 
translation, mitochondrial function and synaptic plasticity. 
Notably, we found that mTOR, an important protein in 
regulating all these biological targets, is inhibited as 
revealed by bioinformatic analysis of proteome data. It 
has been shown that inhibition of mTOR is beneficial 
for synapse-dependent neuroprotection in transgenic 
AD mouse models reducing the levels of amyloid beta 
[34] and abrogating tau-mediated neurotoxicity by using 
systemic rapamycin [35]. Noteworthy, inhibition of 
mTOR signaling seems to be inversely correlated with 
TNFα expression in an AD mouse model (APP
swe
PS1
dE9
) 
compared to wildtype control mice within the neocortex 
and hippocampus [36]. The elevation of synaptic 
plasticity-regulating and neuroprotective-acting p-CREB 
levels correlate well with the biological down-stream 
effects of indicated mTOR inhibition in HT22 cells at 
a dose of 10.0 ng/ml TNFα in our study. Furthermore, 
Oncotarget60232www.impactjournals.com/oncotarget
the reduction in PKA activity as revealed by motif-
immunoblotting is also in agreement with mTOR 
inhibition as the pharmacological elevation of cAMP – an 
upstream inducer of PKA signaling - in mouse embryonic 
fibroblasts and HEK293 cells inhibits mTORC1 activation 
via a PKA-dependent mechanism [37].
Moreover, it has been reported that the bioenergetic 
effect of mTOR inhibition in neurons significantly 
preserves neuronal ATP levels, particularly when oxidative 
phosphorylation is impaired [38]. Our data indicated that 
oxidative phosphorylation is affected by TNFα stimulation 
in HT22 cells influencing protein abundances of Complex 
I, -III, -IV and -V subunits. As the mitochondrial antibody 
cocktail used for immunoblotting consists only of the core 
proteins important for the assembly of the mitochondrial 
complex, the discrepancy between proteomics and 
immunoblotting data, particularly in the case of Complex 
V, is not unexpected and has been observed before 
[39, 40]. Neurons have a high ATP demand [41], and a 
reduction in ATP levels lead to profound decrease in 
neuronal viability [42]. Using a dopaminergic neuronal 
cell line (SH-SY5Y), it was also shown that TNFα alters 
Complex I activity, decreases ATP levels and increases 
ROS levels and mitochondrial turnover [43]. In contrary, 
we did not observe any changes in ROS level or MitoMP 
in human neurons treated with TNFα, which was seen 
Figure 7: Neuroinflammation induced by LPS in TNFα knockout mice impairs cognitive ability. (A and B) Hippocampus-
dependent cognitive ability was explored in the Barnes maze in unmanipulated (A) and LPS-treated (B) female C57BL/6 (filled circles) 
and TNFα-KO (open circles) mice. The escape latency represents the group mean of the average latency for 4 trials per mouse during the 
6 days test period. Mice in (B) received an intraperitoneal injection of LPS (0.5 mg/kg of serum E-coli 0111:B4), 7 and 4 days prior to the 
Barnes maze learning experience. Error bars represent standard error of the mean [67]. (A) C57BL/6 mice (n = 16) and TNFα-KO mice (n 
= 11) showed similar learning ability during the acquisition phase. Two-way ANOVA, repeated measures: Interaction, F(5,125) = 0.45, P = 
0.0010; Group, F(1,25) = 0.81, P = 0,3779; Time, F(5,125) = 74,36, P < 0,0001; Matching, F(5,125) = 74.36, P <= 0,0001. Sidak’s multiple 
comparison test: ns, for all comparisons. (B) In comparison, LPS injection seriously impaired the learning ability of the TNFα-KO mice 
(n = 8), but not in the C57BL/6 mice (n = 8). LPS-injected TNFα-KO mice consistently showed a significant higher latency in locating 
the goal box. Two-way ANOVA, repeated measures: Interaction, F(5,70) = 4.68, P = 0.0010; Group, F(1,14) = 50.85, P < 0,0001; Time, 
F(5,70) = 59,23, P < 0,0001; Matching, F(14,70) = 3.03, P = 0,0011. Sidak’s multiple comparison test, ***P < 0,001; ****P < 0,0001. 
KO; knockout, ns; not significant, LPS; lipopolysaccharide. (C–E) Immunoblotting of CREB and p-CREB of hippocampus from three-
month-old C57BL/6 and TNFα knockout mice (male and female) to explore the connection between TNFα and CREB signaling under 
physiological and inflammatory conditions. Mice were treated with a single intraperitoneal injection of PBS or LPS (0.5 mg/kg of serum 
E-coli 0111:B4) in sterile PBS and were sacrificed four hours after the injection. Intensities of protein CREB and p-CREB were normalised 
against respective total lane intensity of Ponceau staining. Statistical analysis was performed by using unpaired Student´s t-test (n = 3–6/
treatment group & genotype, total number of mice: n = 17). Bars represent the mean±SEM; Representative images of CREB and p-CREB 
immunoblotting and Ponceau stainings are shown in panel E. 
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in HT22 cells by Doll et al. [13]. We believe that this 
is due to the intrinsic molecular and cellular differences 
of the used neuronal cell lines (SH-SY5Y and HT22) in 
comparison to our human stem cell-derived neurons.
The increase in cell proliferation that we observed 
at 0.1, 1.0 and 10.0 ng/ml TNFα in human neurons has 
also been found by others. Bernardino et al. demonstrated 
that the exposure of murine subventricular neuronal 
cultures to 1.0 and 10.0 ng/ml mouse or 1.0 ng/ml human 
recombinant TNFα resulted in increased differentiation of 
cells displaying a neuronal-like calcium-mediated profile 
of responses, compared with the predominant profile of 
immature cells observed in non-treated control cultures 
[44]. Moreover, by using neutralizing antibodies for each 
TNFα receptor, they found that the pro-neurogenic effect 
of 1.0 ng/ml TNFα is mediated via TNFR1 activation. 
Interestingly, exposure of these cultures to 1.0 ng/ml TNFα 
induced cell proliferation, whereas 10.0 and 100.0 ng/ml 
TNFα induced apoptotic cell death [44]. The pro-survival 
molecular mechanism at 1.0 ng/ml TNFα stimulation 
in human neurons of our study may be attributable by 
decreased expression of p-BCLAF1 (Bcl-2-associated 
transcription factor 1) at Ser658 that is a positive regulator 
of apoptosis. 
Noteworthy, our mRNA analysis revealed changes 
in several synaptic plasticity-regulating genes particular in 
expression levels of neuroreceptors in human neurons with 
1.0 ng/ml TNFα stimulation over 24 hours. There, we noted 
that CREB was significantly down-regulated whereas CREB 
levels were unchanged by immunoblotting and proteomics 
experiments. CREB knockdown in human neurons led to 
changes in CREB-mediated signaling (Signaling of Rho 
family GTPases and CREB Signaling in Neurons) as 
expected. In comparison, CREB knockdown followed by 
TNFα stimulation indicated a balance of CREB signaling as 
revealed by immunoblotting and signaling pathway analysis 
of proteomic and phospho-proteomic data. These data 
indicate that TNFα and CREB signaling are interconnected 
in neurons that could be based on the cAMP-responsive 
element (CRE) that TNFα poses as reviewed elsewhere 
[45]. Thus, TNFα can modulate the signaling processes in 
neurons as well as learning and memory response to LPS-
induced neuroinflammation as we demonstrated in our 
hippocampus-dependent behavioural testing. 
To investigate how TNF affects learning ability, 
we exposed groups of TNFα knockout and age-matched 
C57BL/6 mice to the Barnes maze. We did not observe 
any learning deficits in TNFα knockout mice using our 
Barnes maze protocol. This is in line with previous reports 
in TNFα knockout mice where no learning impairments 
are observed during the acquisition phase [46, 47]. We 
challenged the TNFα knockout mice and age-matched 
C57BL/6 mice with LPS-induced inflammation prior to 
learning. We observed clear learning impairments, after 
sickness behaviour had ceased, in the TNFα knockout 
mice, indicating that TNFα plays a homeostatic role 
during neuroinflammation as has previously been 
suggested by others [48]. We also expected to find learning 
impairments in LPS-injected C57BL/6 mice, since LPS 
has been reported to impact on neurogenesis [49–51] 
and induce apoptosis of neurons in the subgranular 
zone [52]. However, we found that inflammation prior 
to learning essentially did not affect C57BL/6 mice 
compared to age-matched C57BL/6 mice. Others have 
shown learning deficits after LPS-injections in adult 
C57BL/6 mice using the Morris Water maze, yet, LPS 
injections were given 4 hours prior to learning [53] and 
the mice probably displayed sickness behaviour, which 
affects locomotor activity [26]. We did, however, find a 
slight learning impairment in LPS-treated 9-month-old 
C57BL/6 mice, in line with studies showing that aging 
causes a greater inflammatory response [54], which could 
cause greater impairments in learning ability. Importantly, 
we demonstrated that LPS- but not PBS-stimulation 
reduces p-CREB levels in TNFα-KO mice but not in 
WT mice in the hippocampus 4 hours after stimulation. 
Phosphorylated CREB is the active form and is implicated 
in the regulation of development, protection, learning, 
memory and plasticity in the nerve system [55]. Thus, 
ameliorating the levels of p-CREB in the hippocampus 
affect CREB signaling that may explain the reduced 
memory and learning performance in our hippocampus-
dependent Barnes maze experiment. Whether or not these 
effects might also influence hippocampal neurogenesis, as 
might be inferred by studies by others [25], remains to be 
determined. 
Our data suggest that the learning ability does not 
depend on TNFα but that TNFα preserves the learning 
and memory ability during episodes of neuroinflammation 
resembling the persistent neuroinflammation observed 
in AD. This may be based on modulation of CREB as 
revealed by our in vitro and in vivo studies, however, a 
deeper molecular analysis is necessary to clarify this 
connection in our model. 
MATERIALS AND METHODS
Cultivation of neuronal HT22 cells and human 
neurons 
HT22 cells (immortalised primary neurons from 
mouse hippocampus) were originally kindly provided by J. 
Lewerenz (Department of Neurology, University Hospital 
Hamburg-Eppendorf, Hamburg, Germany) [56] and were 
maintained in proliferation state in the laboratory of S. 
Tapio (Institute of Radiation Biology, Helmholtz Zentrum 
München, Munich, Germany) from where we received 
a frozen aliquot. The cells were grown in DMEM with 
GlutaMAX, 10% New Born Calf Serum and 1% 100 mM 
sodium pyruvate in poly-L-ornithine coated T175 flasks 
without antibotics at 37°C and 5% CO
2
 in air. Cells were 
incubated with 0 ng/ml (sterile water), 0.1 ng/ml, 1.0 
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ng/ml, 10.0 ng/ml and 100 ng/ml TNFα (active mouse 
TNFα full length protein – Abcam (ab9740)) for 
30 minutes or 24 hours. Three biological replicates 
per condition and time point were used. Cells were 
washed with ice-cold phosphate-buffered saline (PBS). 
Subsequently, cells were scraped off in ice-cold PBS with 
phosphatase and protease inhibitors, centrifuged 2 minutes 
at 300 × g (4°C) and the supernatant was discarded. The 
cell pellets were dissolved in ice-cold PBS and centrifuged 
again. The supernatant was discarded and the cell pellets 
were frozen at −20°C until further processing.
Human neurons were generated by differentiation of 
neural stem cells (NSCs) that were derived from human 
embryonic stem cell (XCell Science Inc). Cell expansion 
and differentiation into mature neurons was performed 
according to the company guidelines and as previously 
described [57]. In brief, the differentiation process went 
through three phases including proliferation, induction 
and maturation. NSCs were thawed and seeded into 
Geltrex (1:100) (Life Technologies) coated plates with 
Neurobasal Medium (Invitrogen) supplemented with 
20 ng/ml bFGF (R&D systems), 1× B27 (Invitrogen), 
20 mM MEM NEAA (Invitrogen), 20 mM GlutaMax 
(Invitrogen) and 1% Penicillin/Streptomycin (Invitrogen) 
and grown for several passages using StemPro® Accutase 
(Life Technologies) performed under routine cell culture 
conditions before starting the differentiation process.
For inducing NSCs into neuronal precursors, the 
proliferating cells were seeded at a density of 20000 cells/
cm2 into Poly-L-ornithin (PLO) (Sigma Aldrich) and 
Laminin (Sigma Aldrich) coated dishes in Neurobasal 
medium supplemented with the factors described above. 
At day 2, the medium was changed to Neural Induction 
Basal Medium (XCell Science) with Neuronal Induction 
Supplement A, B and C (XCell Science) and cells were 
induced for 6 days with medium change every second 
day. For the maturation phase, the neuronal precursor 
cells were grown into PLO/laminin coated dishes in 
Neuronal Maturation Basal Medium (XCell Science) 
supplemented with Neuronal Maturation Supplement A at 
a density of 35.000 cells/cm2 and grown for 8 days. During 
the maturation process, the medium was changed every 
second day and cells were not passaged allowing them to 
fully differentiate into mature neurons. 
Cells (untransfected, control-transfected or 
transfected for CREB knockdown) were incubated 
with 0 ng/ml (sterile water, negative control), 1.0 ng/ml 
TNFα (active human TNFα full length protein – Abcam 
(ab83544)) or 50 µM H
2
O
2 
(positive control; 31642, 
Sigma) for 24 hours. Three biological replicates per 
condition and time point were used. Cells were washed 
with ice-cold PBS. Subsequently, cells were scraped off 
in ice-cold PBS with phosphatase and protease inhibitors, 
centrifuged 2 minutes at 300 × g (4°C) and the supernatant 
was discarded. The cell pellet was dissolved in ice-cold 
PBS and centrifuged again. The supernatant was discarded 
and the cell pellets were frozen at −20°C until further 
processing.
Immunofluorescence
For double immunofluorescence staining, NSCs 
were grown in 24-well plates containing glass coverslips 
(VWR) essentially as described above regarding surface 
coating, medium and cell density. After differentiation, 
cells were fixed in 4% paraformaldehyde (PFA; Sigma) 
in PBS for 25 min at room temperature (RT). For gamma-
aminobutyric acid (GABA) staining, cells were fixed in 
4% PFA and 0.05% glutaraldehyde (Sigma). 
Cells were rinsed with 0.05 M Tris-buffered saline 
(TBS)/0.1% Triton-X-100 (Sigma), then preincubated 
with TBS/5% goat serum (Gibco) according to the host 
of the secondary antibody, and incubated with a mixture 
of two of the following primary antibodies diluted in 
TBS/5% goat serum for 24 hrs at 4°C. Antibodies were 
used at the following concentrations: glial fibrillary 
acidic protein (GFAP; rabbit anti-; DAKO) 1:4000; β-tub 
III (mouse anti; Sigma) 1:2000; GABA (rabbit anti-; 
Chemicon) 1:500 and Ki67 (mouse anti-; BD Pharmingen) 
1:500 in TBS/5% goat serum. Subsequently, cultures were 
incubated with a mixture of Alexa Fluor® 555 conjugated 
anti-mouse IgG and Alexa Fluor® 488 conjugated anti-
rabbit IgG at 1:200 for two hrs at RT. Cell nuclei were 
counterstained with 4′,6-diamidino-2-phenylindole 
(DAPI; Sigma) at 10 µM in TBS. Cultures were mounted 
onto glass slides with Prolong® Gold mounting medium 
(Molecular Probes). Images were recorded using a 
Zeiss Axiophot epifluorescence microscope connected 
to a Leica DC300 camera and processed using Adobe® 
Photoshop® software.
Transfection of human neurons 
RNA-oligonucleotides were used to 
knockdown CREB protein (Unspecific_AllStars_1 
(FlexiTube siRNA premix 1027420, Qiagen) 
as negative control and Hs_CREB_5 (siRNA5) 
(SI00299894 – AACCAAGTTGTTGTTCAAGCT, 
Qiagen) and Hs_CREB_7 (siRNA7) (SI00299908 
– AAGCCCAGCCACAGATTGCCA, Qiagen) for 
knockdown of target protein). Unspecific_AllStars_1 
was dissolved in 625 µl RNAse-free water (10 µM stock 
solution) whereas the siRNAs to knockdown CREB 
were dissolved in each 100 µl RNAse-free water (10 µM 
stock solution). 5 µl of each solution was mixed in 
250 µl Neuronal maturation media. 15 µl Lipofectamine 
RNAiMax (13778150, Thermo Fisher Scientific) was 
dissolved in 250 µl serum-free Neuronal maturation media 
as well. Subsequently, 250 µl of siRNA-containing media 
was mixed with 250 µl lipofectamine containing media 
and incubated for 40 minutes at RT. The final siRNA/
FlexiTube siRNA concentration per 10 cm petri dish was 
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50 pmol (500 µl siRNA-lipid media complex per well) 
with a total media volume of 10 ml. The transfection of 
human neurons started 24 hours before stimulation with/
without TNFα. 
Cell viability and Caspase 3/7 activity assays
For both HT22 cells and the human stem cell-
derived neurons, cell viability and caspase activity were 
determined using CellTiter-Glo® Cell viability assay and 
Caspase-Glo® 3/7 assay, respectively (both Promega). 
Cells were cultured as described above at a density of 
2500 or 5000 (HT22) and 7000 cells per well (human 
neurons) in white polystyrene flat-bottomed 96-well 
plates. The cells were stimulated with 0.1, 1, 10 or 100 
ng/ml TNFα and untreated cells served as control. After 
24 hrs of stimulation, CellTiter-Glo or Caspase-Glo 
reagents were added to each well according to the 
manufacturer’s instructions. After 10 min (CellTiter-Glo) 
or 30 min (Caspase-Glo) at RT, the luminescence signals 
were measured against medium (wells without cells) using 
a BMG fluostar Omega Plate reader (BMG Labtech).
Reactive oxygen species detection and 
mitochondrial membrane potential assay
Oxidative stress and mitochondrial membrane 
potential (MitoMP) were measured for the human stem 
cell-derived neurons with a reactive oxygen species 
(ROS) detection assay (Abcam) and a MitoMP assay (Cell 
Signaling). Cells were cultured as described above at a 
density of 7000 cells per well in white polystyrene flat-
bottomed 96-well plates [58]. The cells were stimulated 
with 0.1, 1.0, 10.0 or 100.0 ng/ml TNFα and untreated 
cells served as control. For the ROS assay, after 24 hrs of 
stimulation the cells were incubated for 60 min at 37oC 
with the ROS Red Dye working solution. Thereafter, some 
cells were treated with 10 μM or 20 μM DMSO for 15 min 
as positive controls whereas the fluorescence signal 
(Ex490/Em620, bottom optics) was measured against 
medium (wells without cells) using a BMG fluostar 
Omega Plate reader (BMG Labtech).
For the MitoMP assay, after 24 hrs of stimulation 
the cells were incubated with 2 μM JC-1 for 15 min. Some 
non-stimulated cells were incubated with 50 μM CCCP 
for 5 min before adding JC-1 serving as positive controls. 
Thereafter cells were washed with PBS and added PBS 
before measuring the fluorescence signal (Ex490/Em520) 
against medium (wells without cells) using a BMG fluostar 
Omega Plate reader (BMG Labtech).
Cell lysis and protein reduction
Cell pellets were lysed and reduced in 6 M urea, 2 M 
thiourea and 10 mM DTT at RT. Afterwards, samples were 
diluted 10 times by adding 20 mM TEAB, pH 7.5. After 
vortexing and sonication, a protein aliquot was taken out 
and stored at −20°C for Western blotting. A total of 60 µg 
protein per condition were used for mass spectrometry-
based proteomics.  
Protein alkylation and enzymatic digestion
A total of 60 µg of proteins were alkylated in 
20 mM iodoacetamide (IAA) for 30 minutes in the dark 
at RT. Subsequently, trypsin (1:50 (w/w) trypsin:protein) 
was added and the solution was incubated overnight at 
37°C. Protein and peptide quantification was performed by 
fluorometric quantification (QubitTM – Life Technologies). 
The peptide solution was dried in a vacuum centrifuge 
before TMT labelling.
TMT10-plex labelling
Three and two biological replicates were used for 
HT22 cells and human neurons, respectively. The labelling 
was performed according to manufacturer´s instruction. 
The labelled peptides of each condition were mixed 
1:1:1:1:1:1:1:1:1:1, dried down and stored for further 
enrichment and analysis. 
Enrichment and purification of phosphorylated 
peptides using TiO2
The workflow is described in detail by Larsen et al. 
[59]. Briefly, the combined labelled peptides (600 µg 
peptides in total) were dissolved in TiO
2
 loading buffer 
(80% acetonitrile (ACN), 5% trifluoroacetic acid (TFA) 
and 1 M glycolic acid) and incubated with 3.6 mg 
of TiO
2
 (titansphere TiO
2
, 5µm; a kind gift from GL 
Sciences, Japan) beads for 30 minutes at RT. The beads 
were sequentially washed with TiO
2
 loading buffer, 80% 
ACN/1% TFA and 10% ACN/0.1% TFA. Phosphorylated 
peptides were eluted with 1.5% ammonium hydroxide 
solution, pH 11.3, and dried. The flow-through was 
incubated again with TiO
2
 (1.8 mg) and processed as 
before and the two TiO
2 
beads approaches were combined. 
The unbound TiO
2 
fraction and the combined washing 
fractions contain unmodified peptides. All the eluates 
were dried and desalted on micro-columns before capillary 
hydrophilic interaction liquid chromatography (HILIC) 
fractionation.
Sample desalting with R2/R3 micro-column
The samples were desalted before HILIC 
fractionation using home-made P200-tip-based columns 
packed with equal ratios of Poros R2 (Oligo R2 Reversed 
Phase Resin 1-1112-46, Applied Biosystems) and Poros 
R3 (OligoR3 Reversed Phase Resin 1-1339-03, Applied 
Biosystems) reversed-phase resin material. The end of 
the tip was blocked with C
8
 material (Model 2314, 3 m 
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EmporeTM C8). The column was prepared by short 
centrifugation (1000× g) of the R3 reversed-phase resin 
(100% ACN). The column was equilibrated with 0.1% 
TFA and centrifuged again. The acidified samples were 
loaded onto the columns and washed / centrifuged three 
times with 0.1% TFA. Peptides were eluted with 60% 
ACN, 0.1% TFA and dried.    
HILIC fractionation 
The unmodified and phosphorylated peptide samples 
were fractionated prior to nano liquid chromatography-
tandem mass spectrometry (nLC-MS/MS) analysis using 
HILIC as described previously [60, 61]. Peptides were 
dissolved in 90% ACN, 0.1% TFA (solvent B) and loaded 
onto a 450 μm OD × 320 μm ID × 17 cm micro-capillary 
column packed with TSK Amide-80 (3 μm; Tosoh 
Bioscience) using an Agilent 1200 Series HPLC (Agilent). 
The peptides were separated using a gradient from 
100–60% solvent B (A = 0.1% TFA) in 30 min at a flow-
rate of 6 μl/min. Fractions were collected every 1 min 
based on the UV chromatogram. Subsequently, the peptide 
fractions were dried by vacuum centrifugation.
Reversed-phase nanoLC-ESI-MS/MS 
The peptides (resuspended in 0.1% formic acid 
(FA)) were automatically injected and loaded on a 
ReproSil-Pur C18 AQ (Dr. Maisch, Ammerbuch-
Entringen, Germany) in-house packed trap column 
(2 cm × 100 µm inner diameter; 5 µm). The peptides were 
separated at 250 nl/min on an analytical ReproSil-Pur 
C18 AQ (Dr. Maisch, Ammerbuch-Entringen, Germany) 
packed in-house column (17 cm × 75 µm; 3 µm) by 
reversed phase chromatography which was operated on 
an EASY-nanoLC system (Thermo Fisher Scientific, 
Odense, Denmark). Mobile phase was 95% ACN/ 0.1% 
FA (B) and water/0.1% FA (A). The gradient was from 
1% to 30% solvent B in 80 min, 30–50% B in 10 min, 
50–100% B in 5 min and 8 min at 100% B. The nano-
LC was online connected to a Q Exactive HF Hybrid 
Quadrupole-Orbitrap mass spectrometer (Thermo Fisher 
Scientific) operating in positive ion mode and using data-
dependent acquisition. The Orbitrap acquired the full MS 
scan with an automatic gain control (AGC) target value 
of 3e6 ions and a maximum fill time of 100 ms. Each MS 
scan was acquired at high-resolution (120,000 full-width 
half maximum (FWHM) at m/z 200 in the Orbitrap with 
a mass range of 400–1400 Da. The 12 most abundant 
peptide ions were selected from the MS for higher energy 
collision-induced dissociation (HCD) fragmentation 
(collision energy: 34 V) if they were at least doubly 
charged. Fragmentation was performed at high resolution 
(60,000 FWHM) for a target of 1e5 and a maximum 
injection time of 60 ms using an isolation window of 
1.2 m/z and a dynamic exclusion of 20 s. 
Data analysis of mass spectrometry experiments
Raw data were searched against the Swissprot 
database and Uniprot mouse/human reference database 
via Mascot (v2.3.02, Matrix Science) and Sequest HT 
search engines, respectively, using Proteome Discoverer 
(v1.4.1.14, Thermo Fisher Scientific). A precursor mass 
tolerance of 10 ppm and a product ion mass tolerance 
of 0.02 Da were applied allowing not more than one 
missed cleavage for trypsin. Fixed modifications included 
carbamidomethylation of Cys and TMT10-plex labeling 
for Lys and N-terminal. Variable modifications contained 
phosphorylation on Ser/Thr/Tyr. The TMT10plex datasets 
were quantified using the centroid peak intensity with 
the “reporter ions quantifier” node. To ensure a high-
confident identification of peptides, we used the Mascot 
percolator algorithm (q value filter set to 0.01), Mascot 
and Sequest HT peptide rank 1 and a cut-off value of 
Mascot score ≥ 22 as well as Sequest HT ΔCn of 0.1. 
Moreover, a cut-off value of Xcorr score for charge states 
of +1, +2, +3 and +4 higher than 1.5, 2, 2.25 and 2.5, 
were considered for further analysis. Subsequently, these 
peptides were filtered against a Decoy database resulting 
into a false discovery rate (FDR) of 0.01 (FDR < 0.01). 
Quantification was performed on the log2-values of the 
measured peptide reporter ion intensities and the data were 
normalized based on the median. Modified peptides were 
merged with the R Rollup function (http://www.omics.pnl.
gov) allowing for one-hit-wonders and using the mean of 
the normalized intensities for each peptide. Quantification 
of proteins was obtained by merging the unmodified 
peptides with the R Rollup function considering at least 2 
unique peptides by not allowing for one-hit-wonders and 
using the mean of the intensities. Subsequently, the mean 
over the experimental conditions for each peptide in each 
replicate was subtracted in order to merge the data from 
different replicates. PhosphoRS was used to confidently 
localise phosphorylation sites with a confidence filter of 
95%. Phosphorylated peptides were normalized based on 
the protein expression in each of the replicates including 
the proteins with only one unique peptide to ensure that 
deregulation occurred on post-translation modification 
(PTM) level and not on protein level. Deregulated 
proteins and phosphorylated proteins were regarded to 
be significantly deregulated if they fulfilled a p-value 
of <0.01 regarding HT22 cell study (n = 3). We applied 
combined limma and rank product tests [62], subsequently 
corrected for multiple testing according to Storey. In 
case of human neurons, a fold-change threshold of ± 1.3 
accompanied with a maximal standard deviation of 30% 
was used (n = 2) due to sample generation limitations. 
These filtering parameters of proteomics data sets were 
successfully applied recently within in vitro/in vivo 
projects in the field of neuroscience [23, 40, 63]. 
The mass spectrometry proteomics data have been 
deposited to the ProteomeXchange Consortium [64] via 
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the PRIDE partner repository with the dataset identifier 
PXD005675 (username: reviewer88432@ebi.ac.uk, 
password: nNWGP0Vk).
Bioinformatics analysis of protein classes and 
affected signaling pathways
Deregulated proteins were categorised into protein 
classes using PANTHER (Protein Analysis Through 
Evolutionary Relationships) classification system software 
(http://www.pantherdb.org) and the general annotation 
from UniProt (http://uniprot.org). The analyses of affected 
signaling pathways from all deregulated proteins and 
PTM profile of proteins were performed independently 
with the INGENUITY Pathway Analysis [43] (http://
www.ingenuity.com) software tool that comprises 
curated information from databases of experimental and 
predictive origin, enabling discovery of highly represented 
functions and pathways. The mean of the ratios of all 
deregulated phosphorylated peptides per protein was 
used for signaling pathway analysis. Network analysis 
was performed by uploading separately the deregulated 
unmodified and phosphorylated proteins. We used only the 
database information of experimental and predictive origin 
regarding central nervous system to be confident about the 
potential affected signaling pathways. The IPA comparison 
analysis takes into account the signaling pathway 
rank according to the calculated p-value and reports it 
hierarchically. The software generates significance values 
(p-values) between each biological or molecular event 
and the imported proteins based on the Fisher´s exact test 
(p ≤ 0.05). Upstream regulator analysis performed by IPA 
software was used to get more information about pathway 
nodes that are overlapping by the uploaded deregulated 
lists of found hits. A z-score greater 2 or smaller than −2 
was used as significance level.  
Quantification of proteins and phosphorylation-
motifs by immunoblotting
Protein extracts (15 µg) were separated on 4–12% 
Bolt Bis-Tris gradient gels (NW04125Box, Novex) and 
transferred to polyvinylidene fluoride (PVDF) membranes 
via the TransBlot SD Semi-Dry Transfer Cell Blotter 
system (Biorad). The protein content on the membranes 
was visualised with Ponceau S. The membranes were 
incubated in blocking buffer (5% milk) washed and 
incubated overnight at 4°C with primary antibody 
dilutions as recommended by the manufacturer (Phospho-
PKC Substrate Motif (R/KXpSX(R/K) MultiMab 
Rabbit Monoclonal Antibody – #6967, Cell Signaling; 
Phospho-PKA Substrate (RRXS*/T*) (100G7E) Rabbit 
Monoclonal Antibody - #9624, Cell Signaling; rabbit 
polyclonal antibody against p44/42 MAPK (Erk1/2) - 
#9102, Cell Signaling; rabbit polyclonal antibody against 
phospho-p44/p42 MAPK (Erk1/2) (Thr202/Tyr204) - 
#9101, Cell Signaling; goat polyclonal antibody against 
GAPDH – ab9483, Abcam; murine monoclonal antibody 
against CREB (clone 86B10) - #9104, Cell Signaling; 
rabbit monoclonal antibody against phospho-CREB 
(Ser133) (clone 87G3) - #9198, Cell Signaling; total 
OXPHOS murine monoclonal antibody cocktail against 
CV-ATP5A, CIII-UQRC2, CII-SDHB and CI-NDUFB8 – 
ab110413, Abcam). 
The blots were washed and incubated with 
horseradish peroxidase-conjugated secondary antibody 
(anti-rabbit IgG, HRP-linked antibody - #7074, Cell 
Signaling, anti-mouse IgG, HRP-linked antibody – 
ab6728, Abcam or anti-goat IgG, HRP-linked antibody – 
ab6741, Abcam) in 5% milk or 3% bovine serum albumin 
(BSA; for phospho antibodies) for 2 hours. Subsequently, 
blots were washed and developed with ECL system 
(LuminataTM Forte Western HRP Substrate, WBLUF0100, 
Millipore) using standard protocol from the manufacturer. 
Immunoblots were considered for quantification if (i) the 
pattern and intensity of lanes stained with PonceauS were 
equal and total lane intensity of the PonceauS-stained 
proteins was similar within the biological replicates. For 
phospho-motif immunoblots, the total lane intensity was 
selected as a representative indicator of global changes 
in PKA- and PKC-phospho motifs. Immunoblots were 
quantified with TotalLab TL100 software (www.totallab.
com) using software-suggested background correction. 
Each band was normalised against the total lane intensity 
obtained by Ponceau S or against GAPDH that was not 
changed during our proteomics analysis. Fold-changes 
were calculated between TNFα-stimulated and control 
samples. Three biological replicates were used for 
statistical analysis (Student´s t-test, unpaired) with a 
significance threshold of 0.05.
Isolation of total RNA and pathway-focused gene 
expression analysis related to synaptic plasticity 
via quantitative PCR
Total RNA from human neurons (control and 
1.0 ng/ml TNFα for 24 hours; n = 3) was isolated and 
purified by mirVanaTM Isolation Kit (Ambion) according 
to the manufacturer´s instructions. Total RNA was 
eluted with nuclease-free water. The optical density 
(OD) ratio of 260/280 was measured using a Nanodrop 
spectrophotometer (PeqLab Biotechnology); it ranged 
between 1.9 and 2.1. Eluates were stored at −20°C until 
further analysis.
The RNA isolates (100 ng) were used to quantify 
the gene expression of 84 mRNA transcripts related to 
synaptic plasticity (RT2 Profiler Mouse Synaptic Plasticity 
– PAMM-126Z, Qiagen) according to the manufacturer´s 
protocol on a StepOnePlus device (Applied Biosystems). 
The relative expression of each mRNA was normalised 
against the average Ct value of 5 reference genes (ACTB, 
B2M, GAPDH, HPRT1 and RPLP0) using the equation 
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2−ΔΔCt, where ΔΔCt = ΔCtTNFα – ΔCtcontrol and ΔCt = 
Ct
target-mRNA 
– Ct
average-of-5-reference-genes
. Gene expression changes 
were considered significant if they reached a p-value of ≤ 
0.05 (Student´s t-test, unpaired). Three biological replicates 
were used in each group (control and 1.0 ng/ml TNFα).
Behavioural and molecular analysis of TNFα 
knockout and C57BL/6 mice
Mice
For this experiment all mice used were 9-month-old 
female mice. TNFα knockout mice [8, 65] were purchased 
at Jackson Laboratories (USA) and bred on a C57BL/6 
background. Female C57BL/6 mice were purchased 
from Taconic A/S (Denmark) except from a group of 
9-month-old C57BL/6 mice, which was purchased 
from Harlan Laboratories (Netherlands). Mice were 
housed in the Biomedical Laboratory at the University 
of Southern Denmark. All experiments were conducted 
under permission from the Danish Ethical Animal Care 
Committee (Permissions no. 2011/562-67 and 2011/561-
1950). 
Barnes maze experiment - LPS treatment
The effect of TNFα on the learning ability was 
studied in TNFα knockout (n = 11) mice using C57BL/6 
mice (n = 16) as controls. Neuroinflammation was induced 
by intraperitoneal injection of TNFα knockout (n = 8) and 
C57BL/6 mice (n = 8) with lipopolysaccharide (LPS) 
(Serum E-coli 0111:B4, Sigma) injections (i.p) at a dose 
of 0.5 mg/kg at day 7 and 4 prior to learning. 
Barnes maze experiment - behaviour analysis
The Barnes maze [66] was used to study the ability 
of C57BL/6 and TNFα knockout mice to learn during the 
acquisition phase as described recently [67]. The Barnes 
maze is a 92 cm diameter maze with 20 holes distributed 
around the perimeter (Panlab Spain) and the testing was 
performed under a high power lamp source to motivate the 
mice. Two weeks prior evaluation of mice on the Barnes 
maze, the mice were individually housed and placed in a 
room reserved to behavioural assessment. Mice were tested 
in the Barnes maze for 6 consecutive days with 4 trials 
per day. The location of the goal box and distal spatial 
cues were constant during the experiment. Each mouse 
was placed within a cylinder in the middle of the maze 
for 30 seconds. The mouse was then allowed 4 minutes to 
find the goal box and, if not found within 4 minutes, the 
mouse was gently guided towards the goal box by hand. 
When the mouse located the goal box itself, it was kept in 
timeout in the box for the remaining time of the 4 minutes. 
The latency time is the time the mouse spends on the maze 
before finding the goal box. The maze was cleaned with 
70% ethanol between each mouse. Statistical analysis was 
performed using Prism (GraphPad Software, version 6). 
Data are presented as mean ± standard error of the mean. 
Data were analysed using repeated measures (RM) two-
way analysis of variance (ANOVA) followed by Sidak´s 
Multiple Comparison Test. Differences were considered 
significant if P ≤ 0.05. P-values are indicated as follows: 
P ≤ 0.05: *, P < 0.01: **, P < 0.001: ***, and P < 0.0001: 
****. 
Histology
Mice were euthanized by an overdose Pentobarbital 
following by transcardial perfusion with 5 ml PBS and 
20 ml 4% PFA. The brains were thereafter placed in 
20% sucrose overnight, and frozen. Brains were stored 
at −20°C until they were sectioned in a cryostate into 
35 mm thick coronal. Parallel sections spanning the entire 
forebrain were stained with toluidine blue [8].
CREB and p-CREB immunoblotting of hippocampus
Three-month-old C57BL6 wild-type and TNFα 
knockout littermate mice were used to explore the 
connection between TNFα and CREB signaling under 
physiological and inflammatory conditions (n = 3–6/
treatment group & genotype, n = 17). Mice received a 
single intraperitoneal injection with either sterile PBS or 
0.5 mg/kg LPS (Serum E-coli 0111:B4, Sigma, Denmark) 
in sterile PBS (injection volume ~150 µL). Four hours 
after the injections, the mice were killed by cervical 
dislocation and their brains were immediately removed 
and dissected on a Petri dish filled with ice. The left 
hippocampus was heat-stabilized using the StabilizorTM 
T1 (Denator), and subsequently frozen on dry-ice for 
immunoblotting as described earlier. 
CONCLUSIONS
This study shows that several molecular targets and 
signaling pathways induced by TNFα in neurons resemble 
those of AD pathology. It may suggest that TNFα functions 
as a contributing factor to this neurodegenerative disease but 
at the same time has neuroprotective properties regulating 
learning and memory formation under neuroinflammatory 
conditions resembling those noted in AD. 
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